OnKure Therapeutics Inc. Insider Trading
OKUR
Insiders sold 6K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in May 2023.
Get an email when OKUR's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21 | Jason A. Leverone Chief Financial Officer | SoldNo plan | 302 | $2.97 | $897 | 1.6% | Form 4 |
| Sep 21 | Nicholas A Saccomano President and CEO | SoldNo plan | 87 | $2.97 | $258 | 0.8% | Form 4 |
| Jun 22 | Jason A. Leverone Chief Financial Officer | SoldNo plan | 303 | $4.40 | 1K | 1.6% | Form 4 |
| Jun 22 | Nicholas A Saccomano President and CEO | SoldNo plan | 86 | $4.40 | $378 | 0.8% | Form 4 |
| Mar 23 | Jason A. Leverone Chief Financial Officer | SoldNo plan | 301 | $4.16 | 1K | 1.8% | Form 4 |
| Mar 23 | Nicholas A Saccomano President and CEO | SoldNo plan | 86 | $4.16 | $358 | 1.2% | Form 4 |
| Dec 22, 2025 | Jason A. Leverone Chief Financial Officer | SoldNo plan | 302 | $2.97 | $897 | 1.8% | Form 4 |
| Dec 22, 2025 | Nicholas A Saccomano President and CEO | SoldNo plan | 87 | $2.97 | $258 | 1.2% | Form 4 |
| Sep 22, 2025 | Jason A. Leverone Chief Financial Officer | SoldNo plan | 303 | $2.62 | $794 | 2.3% | Form 4 |
| Sep 22, 2025 | Nicholas A Saccomano President and CEO | SoldNo plan | 88 | $2.62 | $231 | 2.4% | Form 4 |
| Jun 23, 2025 | Nicholas A Saccomano President and CEO | SoldNo plan | 88 | $2.38 | $209 | 2.4% | Form 4 |
| Jun 23, 2025 | Jason A. Leverone Chief Financial Officer | SoldNo plan | 303 | $2.38 | $721 | 2.3% | Form 4 |
| May 15, 2025 | Acorn Capital Advisors GP, LLC Large holder | Bought 2 parts | 1,400,000 | $1.85 average | $2.59M | 97% | Form 4 |
| May 15, 2025 | Cormorant Private Healthcare Fund III LP Large holder | SoldNo plan | 1,813,439 | $1.85 | $3.35M | 100% | Form 4 |
| May 12, 2025 | Cormorant Global Healthcare Master Fund, LP Large holder | SoldNo plan | 24,300 | $1.99 | 48K | 1.3% | Form 4 |
| Apr 4, 2025 – Apr 7, 2025 | Nicholas A Saccomano President and CEO | SoldNo plan 2 parts | 874 | $2.94 average | 3K | 19% | Form 4 |
| Apr 4, 2025 – Apr 7, 2025 | Jason A. Leverone Chief Financial Officer | SoldNo plan 2 parts | 3,122 | $2.94 average | 9K | 19% | Form 4 |
- Sep 21No planJason A. LeveroneChief Financial Officer · sold 302 at $2.97$8971.6% of stake
- Sep 21No planNicholas A SaccomanoPresident and CEO · sold 87 at $2.97$2580.8% of stake
- Jun 22No planJason A. LeveroneChief Financial Officer · sold 303 at $4.401K1.6% of stake
- Jun 22No planNicholas A SaccomanoPresident and CEO · sold 86 at $4.40$3780.8% of stake
- Mar 23No planJason A. LeveroneChief Financial Officer · sold 301 at $4.161K1.8% of stake
- Mar 23No planNicholas A SaccomanoPresident and CEO · sold 86 at $4.16$3581.2% of stake
- Dec 22, 2025No planJason A. LeveroneChief Financial Officer · sold 302 at $2.97$8971.8% of stake
- Dec 22, 2025No planNicholas A SaccomanoPresident and CEO · sold 87 at $2.97$2581.2% of stake
- Sep 22, 2025No planJason A. LeveroneChief Financial Officer · sold 303 at $2.62$7942.3% of stake
- Sep 22, 2025No planNicholas A SaccomanoPresident and CEO · sold 88 at $2.62$2312.4% of stake
- Jun 23, 2025No planNicholas A SaccomanoPresident and CEO · sold 88 at $2.38$2092.4% of stake
- Jun 23, 2025No planJason A. LeveroneChief Financial Officer · sold 303 at $2.38$7212.3% of stake
- May 15, 2025Acorn Capital Advisors GP, LLCLarge holder · bought 1,400,000 at avg $1.85$2.59M97% of stake
- May 15, 2025No planCormorant Private Healthcare Fund III LPLarge holder · sold 1,813,439 at $1.85$3.35M100% of stake
- May 12, 2025No planCormorant Global Healthcare Master Fund, LPLarge holder · sold 24,300 at $1.9948K1.3% of stake
- Apr 4, 2025 – Apr 7, 2025No planNicholas A SaccomanoPresident and CEO · sold 874 at avg $2.943K19% of stake
- Apr 4, 2025 – Apr 7, 2025No planJason A. LeveroneChief Financial Officer · sold 3,122 at avg $2.949K19% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with OKUR
Held by ETFs
OKUR is in 2 US ETFs. The largest of them, with OKUR's weight in each:
Spot a number that looks wrong? Check it in OKUR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing OKUR
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.